Zentalis Pharmaceuticals (ZNTL)
(Delayed Data from NSDQ)
$4.22 USD
-0.14 (-3.21%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $4.22 0.00 (0.00%) 7:50 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $-0.91 | 0.00% |
Earnings Summary
For their last quarter, Zentalis Pharmaceuticals (ZNTL) reported earnings of -$1.24 per share, missing the Zacks Consensus Estimate of -$0.83 per share. This reflects a negative earnings surprise of 49.40%. Look out for ZNTL's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of -$0.91 per share, reflecting a year-over-year decrease of 15.19%.
Earnings History
Price & Consensus
Zacks News for ZNTL
Zentalis Stock Up as FDA Lifts Partial Hold on Cancer Drug Studies
ZNTL: What are Zacks experts saying now?
Zacks Private Portfolio Services